tradingkey.logo
tradingkey.logo
Suchen

Rockwell Medical Inc

RMTI
Zur Watchlist hinzufügen
0.792USD
-0.004-0.55%
Handelsschluss 05/15, 16:00ETKurse um 15 Minuten verzögert
31.26MMarktkapitalisierung
VerlustKGV TTM

Rockwell Medical Inc

0.792
-0.004-0.55%

mehr Informationen über Rockwell Medical Inc Unternehmen

Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company is the supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.

Rockwell Medical Inc Informationen

BörsenkürzelRMTI
Name des UnternehmensRockwell Medical Inc
IPO-datumJan 27, 1998
CEOStrobeck (Mark)
Anzahl der mitarbeiter244
WertpapierartOrdinary Share
GeschäftsjahresendeJan 27
Addresse30142 Wixom Road
StadtWIXOM
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl48393
Telefon18004493353
Websitehttps://www.rockwellmed.com/
BörsenkürzelRMTI
IPO-datumJan 27, 1998
CEOStrobeck (Mark)

Führungskräfte von Rockwell Medical Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Mark H. Ravich
Mr. Mark H. Ravich
Independent Director
Independent Director
151.10K
--
Mr. John G. Cooper, CPA
Mr. John G. Cooper, CPA
Independent Director
Independent Director
145.45K
+3.49%
Mr. Timothy Chole
Mr. Timothy Chole
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
125.68K
-1.94%
Dr. Joan Lau, Ph.D.
Dr. Joan Lau, Ph.D.
Independent Director
Independent Director
113.11K
--
Dr. Mark Strobeck, Ph.D.
Dr. Mark Strobeck, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
103.95K
-165.85%
Ms. Megan Timmins, J.D.
Ms. Megan Timmins, J.D.
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
61.85K
-124.77%
Mr. Jesse Neri
Mr. Jesse Neri
Chief Financial Officer, Senior Vice President - Finance
Chief Financial Officer, Senior Vice President - Finance
18.68K
-449.49%
Mr. Robert S. Radie
Mr. Robert S. Radie
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Allen R. Nissenson, M.D.
Dr. Allen R. Nissenson, M.D.
Independent Director
Independent Director
--
--
Ms. Heather R. Hunter
Ms. Heather R. Hunter
Chief Operating Officer
Chief Operating Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Mark H. Ravich
Mr. Mark H. Ravich
Independent Director
Independent Director
151.10K
--
Mr. John G. Cooper, CPA
Mr. John G. Cooper, CPA
Independent Director
Independent Director
145.45K
+3.49%
Mr. Timothy Chole
Mr. Timothy Chole
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
125.68K
-1.94%
Dr. Joan Lau, Ph.D.
Dr. Joan Lau, Ph.D.
Independent Director
Independent Director
113.11K
--
Dr. Mark Strobeck, Ph.D.
Dr. Mark Strobeck, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
103.95K
-165.85%
Ms. Megan Timmins, J.D.
Ms. Megan Timmins, J.D.
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
61.85K
-124.77%

Umsatzaufteilung

FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Concentrate Products
68.93M
0.00%
Drug Products
325.00K
0.00%
Nach RegionUSD
Name
Umsatz
Anteil
United States
60.36M
0.00%
Rest of World
8.90M
0.00%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Concentrate Products
68.93M
0.00%
Drug Products
325.00K
0.00%

Aktionärsstatistik

Aktualisiert: Thu, May 14
Aktualisiert: Thu, May 14
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Irrevocable Larson Family Investment Trust
9.01%
Vanguard Capital Management, LLC
3.00%
Renaissance Technologies LLC
1.19%
Geode Capital Management, L.L.C.
0.92%
Vanguard Fiduciary Trust Co
0.59%
Andere
85.29%
Aktionäre
Aktionäre
Anteil
Irrevocable Larson Family Investment Trust
9.01%
Vanguard Capital Management, LLC
3.00%
Renaissance Technologies LLC
1.19%
Geode Capital Management, L.L.C.
0.92%
Vanguard Fiduciary Trust Co
0.59%
Andere
85.29%
Aktionärstypen
Aktionäre
Anteil
Corporation
9.01%
Investment Advisor
5.96%
Individual Investor
3.30%
Investment Advisor/Hedge Fund
1.63%
Hedge Fund
1.50%
Research Firm
0.28%
Venture Capital
0.16%
Andere
78.16%

Institutionelle Beteiligung

Aktualisiert: Wed, Apr 1
Aktualisiert: Wed, Apr 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q1
98
5.15M
13.04%
-2.20M
2025Q4
93
3.38M
8.58%
-3.83M
2025Q3
98
6.21M
18.04%
-1.88M
2025Q2
119
12.15M
35.56%
-1.45M
2025Q1
124
11.25M
32.97%
-1.96M
2024Q4
123
12.47M
38.59%
-1.21M
2024Q3
113
13.08M
41.13%
+2.79M
2024Q2
102
9.50M
31.23%
+460.06K
2024Q1
118
5.89M
19.90%
-1.12M
2023Q4
118
5.97M
23.48%
-688.25K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Irrevocable Larson Family Investment Trust
3.56M
9.03%
+87.50K
+2.52%
Apr 11, 2025
Renaissance Technologies LLC
468.32K
1.19%
-93.89K
-16.70%
Dec 31, 2025
Geode Capital Management, L.L.C.
364.82K
0.93%
+41.67K
+12.89%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
214.64K
0.54%
-1.45K
-0.67%
Dec 31, 2025
UBS Financial Services, Inc.
139.72K
0.35%
+132.16K
+1749.79%
Dec 31, 2025
Ravich (Mark H)
151.10K
0.38%
+50.00K
+49.45%
May 20, 2025
Cooper (John G)
140.37K
0.36%
-5.08K
-3.49%
Nov 18, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
iShares Micro-Cap ETF
0.01%
Dimensional US Core Equity 1 ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
iShares Micro-Cap ETF
Anteil0.01%
Dimensional US Core Equity 1 ETF
Anteil0%
DFA Dimensional US Sustainability Core 1 ETF
Anteil0%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
Datum
Ex-Dividendentag
Art
Verhältnis
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
KeyAI